{"id":"W2608461130","doi":"10.1200/jco.2017.72.8030","title":"Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Hormonal therapy; Abiraterone acetate; Oncology; Internal medicine; Clinical trial; Chemotherapy; Context (archaeology); Docetaxel; Population; Androgen deprivation therapy; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004617153,0.0005837894,0.001073512,0.001531095,0.00169643,0.005410311,0.002214067,0.008201059,0.03249849],"category_scores_gemma":[0.02356236,0.0005906409,0.001108775,0.00160935,0.0015297,0.002507093,0.001995518,0.006767924,0.02861736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002599553,"about_ca_system_score_gemma":0.007908463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002217452,"about_ca_topic_score_gemma":0.005209538,"domain_scores_codex":[0.9954345,0.001143182,0.0006589846,0.0003329091,0.001985479,0.0004450126],"domain_scores_gemma":[0.9608138,0.003226848,0.004031461,0.001214738,0.02552881,0.005184313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003277318,0.00001692346,0.0001149409,0.0003651026,0.00001014818,0.0000557161,0.00001359201,0.00002032194,0.000200742,0.0003546661,0.9562609,0.04255429],"study_design_scores_gemma":[0.00007955136,0.00003256739,0.0004570514,0.0009993984,0.00002004776,0.0002014459,0.0000452682,0.00005411801,0.0001134812,0.001045186,0.9969369,0.00001498378],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001244097,0.06857719,0.002828987,0.4285669,0.3741244,0.0009672997,0.001648082,0.0005376025,0.1215053],"genre_scores_gemma":[0.0190069,0.1425484,0.01133547,0.279263,0.4425176,0.001581619,0.004933068,0.0005385439,0.09827538],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.03249849,"threshold_uncertainty_score":0.1087182,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4594685778874917,"score_gpt":0.6328043055020732,"score_spread":0.1733357276145815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}